Currently Enrolling Clinical Trials
If you do not find a study that interests you, please consider enrolling in our Research Volunteer Program. You can select the types of studies in which you are interested, and our staff will contact you when a study becomes available in one of those areas.
Filter by Indication:
Adolescent Health
We currently are not recruiting for this indication.
Allergy
COFAR4: Sublingual Immunotherapy for Peanut Allergy: A Randomized,double blind, placebo-contorlled, phase I/II pilot study with a whole peanut extract.
Study Description:
Peanut sublingual immunotherapy study that involves giving increasing dose of peanut allergen gradually to determine if the participant may be able to eat peanut without developing an allergic reaction.
More information about this clinical trial.
A multi-center, randomized, double blind, placebo-controlled parallel group study of the sagery of Levocetirizine diydrochloride oral liquid formulation in children aged 6 monthsto 11 months with symptoms of allergis rhinitis or chronic uticaria.
Study Description:
This study will look at how safe the study drug (levocetirizine dihydrochlorid) is when bening compared to a placebo (sugar pill).
More information about this clinical trial.
Arthritis
We currently are not recruiting for this indication.
Asthma
We currently are not recruiting for this indication.
Behavioral / Development
Metabolic Biomarkers of Autism: Predictive Potential and Genetic Susceptibility
Study Description:
An NIH-sponsored autism research study at Arkansas Children’s Hospital Research Institute is recruiting children 3-10 years of age with the diagnosis of autistic disorder, their siblings, and also control/unaffected children. The study is directed by Dr. S. Jill James, Professor in the Department of Pediatrics, who will analyze blood samples from these children as well as their parents and their siblings to better understand the metabolic pathology that may contribute to the symptoms and development of autism.
The research study is also recruiting children with developmental delay who are 18-36 months of age to test whether specific metabolic biomarkers are predictive of a diagnosis of autism.
More information about this clinical trial.
Treating Oxidative Stress and the Metabolic Pathology of Autism
Study Description:
A privately funded autism research study at Arkansas Children’s Hospital Research Institute is recruiting children 3-6 years of age with the diagnosis of autistic disorder. The study is directed by Dr. S. Jill James, Professor in the Department of Pediatrics, and Dr. Steven Kahler, Professor, Department of Pediatrics Division of Medical Genetics, who will study whether targeted nutritional supplements can improve the health and behavior of autistic children.
More information about this clinical trial.
Endocrine - Diabetes/Growth Hormone
We currently are not recruiting for this indication.
Gastroenterology - Constipation/Crohns/IBS/EE
Pilot stduy to evaluate the Oral absorption, safety an dtolerability of Nepadutant administered as a siingle dose in infants with colic.
Study Description:
This study will look at the amount of study drug (Nepadutant) in the urine of infants with suspected colic after a single dose.
More information about this clinical trial.
General Pediatrics
We currently are not recruiting for this indication.
Head Aches - Migraines
We currently are not recruiting for this indication.
High Blood Pressure
A Multicnter, Randomized, double-blind, parallel-group, evaluation of 12 weeks of Valsartan compared to enalapril on sitting systolic blood pressure in children 6 to 17 years of age.
Study Description:
This study is comparing the study drug (Valsartian) to Enalapril to see which one works best on high blood pressure in children and has the least amount of side effects.
More information about this clinical trial.
The role of ambulatory blood pressure monitoring (ABPM)in interventional trials conducted in children: Detection of "white Coat" hypertension, comparison of ABPM and casual measurements, and Investigation of the placebo effect in children with borderline to mild hypertension.
Study Description:
The study will compare blood pressure measurements taken with the monitor worn by the child to those taken in the doctor's office. The study will also see if a placebo (sugar pill) has any affect on blood pressure in children who have borderline or mild high blood pressure.
More information about this clinical trial.
Infant Nutrition
Beginnings study, Effects of Diet on Metabolism, Body Composition, and Brain function in infants/children.
Study Description:
Have you ever wondered...
-Is Breast(feeding) really best?
-Are chubby babies destined to be overweight adults?
-If soy foods are healthy for me, is soy formula good for babies?
We have! These are just a few of the many questions being answered by the scientists at the Arkansas Children's Nutrition Center (ACNC) through the Beginnings study. The ACNC is one of only six Human Nutrition Research Centers funded by the U.S. Department of Agriculture. The ACNC is located on the campus of the Arkansas Children's Hospital and the scientists are faculty at the University of Arkansas for the Medical Sciences (UAMS).
Beginnings is a long-term research study of infants/children from birth through school age. Moms can enroll their healthy babies between 4-8 weeks old, once they have decided on the right feeding type for their baby - breast milk, milk-based formula, or soy-based formula. We are still enrolling infants in all feeding groups, but we are the most interested in finding Infants fed soy-based formula. Moms and babies come to the ACNC for up to eight study visits during the first year of life, at 1-, 2-, 3-, 4-, 5-, 6-, 9-, and 12 months of age, then annually of the rest of the study. At each visit, we measure the growth, brain function, development and diet of the infant/child. At some visits, we also assess body composition (percent body fat), general development and behavior, and the size of some organs with an ultrasound.
The Beginnings study has been approve by the UAMS Institutional Review Board (IRB), which is an independent committee of scientists, doctors, and community leaders not involved in this research project. The IRB is an ethics board that reviews all research projects to make sure they are safe. Although we cannot pay people to be a part of a research study, we offer benefits such as formula, diapers, travel stipend, gift cards, or other incentives.
For more information about the Beginnings study, please call our Recruiter, Leah Stanley, at (501) 364-3309 or toll-free at (866)423-1311 (toll free). You can also visit us on-line at:www.uams.edu/acnc
More information about this clinical trial.
Infectious Disease
An open-label, parallel-group study to evaluate the single dose pharmacokinetics and safety of doripenem in pediatric patients 3 months to 17 years of age, inclusive.
Study Description:
This study will measure the amount of studydrug (Doripenem)in the blood and urine of children who have received one dose.
More information about this clinical trial.
An open-label study to evaluate the single-dose pharmacokinetics and sagety of ceftobiprole in pediatric subjects 3 months to < 18 years of age undergoing treatment with systemic antibiotics.
Study Description:
The study will measure the amount of study drug (ceftobiprole) in the blood of children after receiving one dose. The study will also see how well children tolerate one dose of the study drug (ceftobiprole).
More information about this clinical trial.
Neurology - Seizures
We currently are not recruiting for this indication.
Obesity
We currently are not recruiting for this indication.
Pain
We currently are not recruiting for this indication.
Psychiatric
We currently are not recruiting for this indication.
Pulmonary - Lung/Cystic Fibrosis
We currently are not recruiting for this indication.
|
